These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
747 related articles for article (PubMed ID: 9832424)
1. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Kurihara S; Hakuno F; Takahashi S Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049 [TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B; Cheng HL; Margolis B; Feldman EL J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA; Surmacz E Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064 [TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin-sensitive and insensitive intracellular signalling pathways in undifferentiated 3T3-L1 cells stimulated by insulin converge with phosphatidylinositol 3-kinase upstream of the Ras mitogen-activated protein kinase cascade. Uehara T; Tokumitsu Y; Nomura Y Eur J Biochem; 1999 Feb; 259(3):801-8. PubMed ID: 10092867 [TBL] [Abstract][Full Text] [Related]
6. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C; Valverde AM; Kahn CR; Benito M Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis. Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219 [TBL] [Abstract][Full Text] [Related]
8. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
9. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors. Daulhac L; Kowalski-Chauvel A; Pradayrol L; Vaysse N; Seva C J Biol Chem; 1999 Jul; 274(29):20657-63. PubMed ID: 10400698 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
11. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes. Valverde AM; Lorenzo M; Pons S; White MF; Benito M Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin-like growth factor-1 receptor and IRS-2 signaling by ethanol in SH-SY5Y neuroblastoma cells. Seiler AE; Ross BN; Rubin R J Neurochem; 2001 Jan; 76(2):573-81. PubMed ID: 11208920 [TBL] [Abstract][Full Text] [Related]
14. Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors. Inoue G; Cheatham B; Kahn CR J Biol Chem; 1996 Nov; 271(45):28206-11. PubMed ID: 8910437 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Thirone AC; Carvalho CR; Saad MJ Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells. Kim B; van Golen CM; Feldman EL Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916 [TBL] [Abstract][Full Text] [Related]
18. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. Zheng WH; Quirion R J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression. Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105 [TBL] [Abstract][Full Text] [Related]